RXDX
|
Prometheus Biosciences, Inc.
|
0.85%
|
US
|
NASDAQ
|
PI
|
Impinj, Inc.
|
0.55%
|
US
|
NASDAQ
|
CLDX
|
Celldex Therapeutics, Inc.
|
0.46%
|
US
|
NASDAQ
|
PRTA
|
Prothena Corporation plc
|
0.45%
|
US
|
NASDAQ
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.44%
|
US
|
NASDAQ
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
0.43%
|
US
|
NASDAQ
|
STR
|
Sitio Royalties Corp.
|
0.42%
|
US
|
NYSE
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.40%
|
US
|
NASDAQ
|
TMDX
|
TransMedics Group, Inc.
|
0.39%
|
US
|
NASDAQ
|
INSW
|
International Seaways, Inc.
|
0.39%
|
US
|
NYSE
|
TDW
|
Tidewater Inc.
|
0.38%
|
US
|
NYSE
|
TBBK
|
The Bancorp, Inc.
|
0.37%
|
US
|
NASDAQ
|
AKRO
|
Akero Therapeutics, Inc.
|
0.36%
|
US
|
NASDAQ
|
AGYS
|
Agilysys, Inc.
|
0.35%
|
US
|
NASDAQ
|
VIVO
|
Meridian Bioscience Inc.
|
0.33%
|
US
|
NASDAQ
|
UEC
|
Uranium Energy Corp.
|
0.32%
|
US
|
AMEX
|
CTS
|
CTS Corporation
|
0.31%
|
US
|
NYSE
|
STEL
|
Stellar Bancorp, Inc.
|
0.30%
|
US
|
NASDAQ
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.30%
|
US
|
NASDAQ
|
MNKD
|
MannKind Corporation
|
0.29%
|
US
|
NASDAQ
|